Clinical Trials Sponsored by Genetron Health

Total 50070 results

Genethon

Recruiting

Gene Therapy for Severe Crigler Najjar Syndrome (CareCN)

Crigler-Najjar Syndrome

Italy, France, Netherlands
Genethon

Active, not recruiting

Gene Therapy for X-linked Chronic Granulomatous Disease (X-CGD) (CGD)

X-Linked Chronic Granulomatous Disease

United Kingdom
Genethon

Active, not recruiting

Long Term Safety Follow up of Haematopoietic Stem Cell Gene Therapy for the Wiskott Aldrich Syndrome (WASFUP)

Wiskott-Aldrich Syndrome

United Kingdom, France
Genethon

Recruiting

Natural History of Duchenne Muscular Dystrophy

Duchenne Muscular Dystrophy

France, United Kingdom
Genethon

Completed

Clinical Study of AAV1-gamma-sarcoglycan Gene Therapy for Limb Girdle Muscular Dystrophy Type 2C

Limb Girdle Muscular Dystrophy Type 2C | Gamma-sarcoglycanopathy

France
Genethon

Active, not recruiting

Natural History Study of Patients With Limb-Girdle Muscular Dystrophy 2I

LGMD2I

Denmark, France, United Kingdom
Genethon

Active, not recruiting

Gene Therapy for X-linked Chronic Granulomatous Disease

X-Linked Chronic Granulomatous Disease

France
Genethon

Completed

Immunity Against AAV in Crigler Najjar Patient

Crigler Najjar Syndrome

France
GeNeuro Innovation SAS

Terminated

A Long-term Extension of Study GNC-401

Multiple Sclerosis

Sweden
ReNeuron Limited

Enrolling by invitation

Long-Term Safety Study of CTX0E03 in Subjects Who Completed PISCES III Study (LTFU)

Ischemic Stroke

United States
ReNeuron Limited

Terminated

Investigation of Neural Stem Cells in Ischemic Stroke (PISCES III)

Ischemic Stroke | Hemiparesis | Chronic Stroke | Arm Paralysis

United States
ReNeuron Limited

Completed

Safety Trial Of CTX Cells In Patients With Lower Limb Ischaemia

Peripheral Arterial Disease

United Kingdom
GeNeuro Innovation SAS

Completed

Clinical Trial Assessing Temelimab Following Rituximab Treatment in Patients With Relapsing Forms of Multiple Sclerosis (ProTEct-MS)

Multiple Sclerosis

Sweden
GeNeuro Innovation SAS

Completed

Safety Study of GNbAC1 in Multiple Sclerosis Patients

Multiple Sclerosis

Switzerland
ReNeuron Limited

Completed

Pilot Investigation of Stem Cells in Stroke (PISCES)

Stroke

United Kingdom
ReNeuron Limited

Active, not recruiting

Safety and Tolerability of hRPC in Retinitis Pigmentosa (hRPCRP)

Retinitis Pigmentosa

United States, United Kingdom, Spain
ReNeuron Limited

Completed

An Ischaemic Stroke Observational Study

Stroke

United Kingdom
ReNeuron Limited

Completed

Observational Study of Ischaemic Stroke (OSIS)

Stroke | Motor Activity

United Kingdom
GeNeuro SA

Active, not recruiting

Temelimab as a Disease Modifying Therapy in Patients With Neuropsychiatric Symptoms in Post-COVID 19 or PASC Syndrome

Post-COVID-19 Syndrome

Switzerland, Italy, Spain
GlySure
Kentron

Unknown

Comparative Study of GlySure Continuous Intra-vascular Glucose Monitoring and Intermittent Monitoring in Medical ICU (MICU)

Blood Glucose Monitoring in Medical ICU
Enteron Pharmaceuticals

Completed

Randomized Study of Oral Beclomethasone Dipropionate With Ten Days of Prednisone for Treatment of Gastrointestinal GVHD

Graft Vs Host Disease | Gastrointestinal Graft-Versus-Host Disease

United States
GeNeuro Australia PTY Ltd

Completed

Single Ascending Doses Study With GNbAC1 in Healthy Male Volunteers

Multiple Sclerosis

Australia
GeNeuro Innovation SAS

Completed

Longitudinal Therapeutically Non-interventional Study of MSRV-Env Burden in Patients With Multiple Sclerosis Disease (LOMBARD)

Multiple Sclerosis (MS) | Clinically Isolated Syndrome (CIS) | Secondary Progressive MS | Primary Progressive MS | Relapsing-Remitting MS

France, Spain, Switzerland
GeNeuro Innovation SAS

Completed

Longitudinal Therapeutically Non-interventional Study of MSRV-Env Burden in Normal Population (CONTROL)

Multiple Sclerosis

France
GeNeuro Innovation SAS

Completed

First-in-Human Study With GNbAC1 in Healthy Volunteers

Multiple Sclerosis
GeNeuro Innovation SAS

Completed

Safety Study of GNbAC1 Monoclonal Antibody in Healthy Male Volunteers

Healthy Volunteers

Germany
ReNeuron Limited

Completed

Pilot Investigation of Stem Cells in Stroke Phase II Efficacy (PISCES-II)

Cerebral Infarction | Hemiparesis | Ischaemic Stroke | Arm Paralysis

United Kingdom
Genethon
Institute of Myology

Completed

Research of Biomarkers in Duchenne Muscular Dystrophy Patients (IBISD)

Duchenne Muscular Dystrophy (DMD)

France
Genethon
Institute of Myology

Unknown

Observational Study of Patients With Duchenne Muscular Dystrophy Theoretically Treatable With Exon 53 Skipping (pre U7-53)

Duchenne Muscular Dystrophy

United Kingdom, France
GenEros Biopharma Hangzhou Ltd

Recruiting

Study of GEC255 in Subjects With Advanced Solid Tumors With KRAS p.G12C Mutation

Advanced Solid Tumors

China
Ruijin Hospital
Hangzhou Genetron Medical Laboratory Co., Ltd.

Recruiting

Urothelial Tumor Risk Genes Detection With Genetron Uro V1 and LC-WGS

Urothelial Carcinoma

China
Genethon
Hôpital Necker-Enfants Malades

Completed

Gene Therapy for WAS

Wiskott-Aldrich Syndrome

France
Centre d'Etude des Cellules Souches
Genethon

Recruiting

Efficacy Study of Daily Administration of VPA in Patients Affected by Wolfram Syndrome (AUDIOWOLF)

Wolfram Syndrome

France, Spain
Genetron Health
Peking University Cancer Hospital & Institute; Shanghai 10th People's Hospital and other collaborators

Completed

Clinical Evaluation of Genetron D842V PCR Kit in GIST Patients

Gastrointestinal Stromal Tumors | GIST

China
GeNeuro Australia PTY Ltd
Southern Star Research Pty Ltd.

Completed

Clinical Trial Assessing the GNbAC1 in Patients With Onset of Type 1 Diabetes Within 4 Years (RAINBOW-T1D)

Diabetes Mellitus Type 1

Australia
Valerion Therapeutics, LLC
Institut de Myologie, France; Genethon

Completed

Prospective, Longitudinal Study of the Natural History and Functional Status of Patients With Myotubular Myopathy (MTM) (MTM)

Myotubular Myopathy

France, Belgium, United States, Canada, Germany, Italy, Spain
Genetron Health
Huashan Hospital; West China Hospital; The First Hospital of Jilin University; Zhejiang...

Completed

Clinical Evaluation of Genetron IDH1 PCR Kit in Glioma Patients

Glioma, Malignant | Glioma, Mixed

China
Genetron Health
Huashan Hospital; West China Hospital; The First Hospital of Jilin University; Zhejiang...

Completed

Clinical Evaluation of Genetron TERT PCR Kit in Glioma Patients

Glioma, Malignant

China
Genervon Biopharmaceuticals, LLC
Columbia University

Completed

Phase 2A Study of GM 608 in Mild to Moderate Parkinson Disease (GAP-PD)

Parkinson's Disease

United States
Genetron Health
Cancer Institute and Hospital, Chinese Academy of Medical Sciences; Henan Cancer... and other collaborators

Completed

Clinical Evaluation of Genetron Lung Cancer Panel in Non-small Cell Lung Cancer Patients

Non-Small Cell Lung Cancer

China
Genetron Health
Piedmont Transplant Institute. 1968 Peachtree Road, NW | 77 Building, 6th...

Not yet recruiting

Novel Biomarker Assay for Biomarker Assay for HCC Detection (GTH_HCC)

Hepato-cellular Carcinoma
Genethon
Institute of Child Health; Great Ormond Street Hospital for Children NHS Foundation...

Completed

Gene Therapy for Wiskott-Aldrich Syndrome (WAS)

Wiskott-Aldrich Syndrome

United Kingdom
Genton Graf Laurence

Completed

Body Composition: a Predictor of Mortality in Subjects Over 65 Years

External Causes of Morbidity and Mortality

Switzerland
Genton Graf Laurence

Recruiting

Microbiota and Pancreatic Cancer Cachexia (EXTRA)

Pancreatic Cancer | Cachexia | Microbiota

Switzerland
Genervon Biopharmaceuticals, LLC
Massachusetts General Hospital; Columbia University

Completed

GM604 Phase 2A Randomized Double-blind Placebo Controlled Pilot Trial in Amyotrophic Lateral Disease (ALS) (GALS)

Amyotrophic Lateral Sclerosis

United States
Genetron Health
First Affiliated Hospital, Sun Yat-Sen University; Tianjin Medical University... and other collaborators

Recruiting

Clinical Evaluation of Genetron TERT/BRAF PCR Kit in Thyroid Cancer Patients

Thyroid Cancer

China
GeNeuro SA
Worldwide Clinical Trials; Institut de Recherches Internationales Servier; Les...

Completed

Clinical Trial Assessing the HERV-W Env Antagonist GNbAC1 for Efficacy in MS (CHANGE-MS)

Multiple Sclerosis, Relapsing-Remitting

Poland, Ukraine, Germany, Spain, Bulgaria, Serbia, Russian Federation, Hungary, Italy, Croatia, Czechia, Estonia
University of California, Los Angeles
National Heart, Lung, and Blood Institute (NHLBI); Boston Children's Hospital; California Institute for Regenerative Medicine (CIRM) and other collaborators

Recruiting

Study of Gene Therapy Using a Lentiviral Vector to Treat X-linked Chronic Granulomatous Disease

Granulomatous Disease, Chronic, X-linked

United States
GeNeuro SA
Worldwide Clinical Trials; Institut de Recherches Internationales Servier; Les...

Terminated

Assessing the HERV-W Env ANtagonist GNbAC1 for Evaluation in an Open Label Long-term Safety Study in Patients With Multiple Sclerosis (ANGEL-MS)

Multiple Sclerosis, Relapsing-Remitting

Estonia, Bulgaria, Croatia, Czechia, Germany, Hungary, Italy, Poland, Russian Federation, Serbia, Spain, Ukraine
Heart Health Research Center
AstraZeneca

Not yet recruiting

Compare the Impact of Xuezhikang and Atorvastatin on Glucose Metabolism in Dyslipidemia Patients With Prediabetes (XTREME)

Metabolism Disorder, Glucose | Metabolism Disorder, Lipid

Clinical Trials Sponsored by Genetron Health

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ireland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations